Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...
Reexamination Certificate
2008-03-18
2008-03-18
Ungar, Susan (Department: 1642)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
C435S007100, C435S007230, C435S007210
Reexamination Certificate
active
10010763
ABSTRACT:
Methods for determining the effectiveness of anticancer agents by determining and comparing growth factor receptor phosphorylation levels in samples obtained by non-invasive procedures before and after anticancer treatments are provided. The invention also provides methods for detecting growth factor receptor phosphorylation in hair follicles and other tissues obtained by non-invasive means.
REFERENCES:
Pollack et al (Proc. Annu Meet AACR, 1997, 38(A4249).
Scardino et al (NCl monographs, 1988, 7:95-103).
Prewett et al (J. Immunotherapy with Emphasis on Tumor Immunology, 1996, 19(6)419-427).
Prewett et al (Clin. Can. Res., 1998, 4:2957-2966).
Akiyama et al., “Growth factor and growth factor receptor localization in the hair follicle bulge and associated tissue in human fetus,”J. Invest. Dermatol., 106(3):391-396, 1996.
Bergler et al., “The expression of epidermal growth factor receptors in the oral mucosa of patients with oral cancer,”Arch. Otorhinolaryngol., 246(3):121-125, 1989.
Bergmann et al., “Insulin-like growth factor I overexpression in human pancreatic cancer. evidence for autocrine and paracrine roles,”Cancer Res., 55:2007-2011, 1995.
Bruns et al., “Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma,”Cancer Res., 60:2926-2935, 2000.
Bruns et al., “In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice,”Neoplasia, 1:50-62, 1999.
Chan et al., “A common human skin tumour is caused by activating mutations in β-catenin,”Nat. Genet., 21:410-413, 1999.
Ciardiello et al., “Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A,”J. Nat'l Cancer Inst., 88:1770-1776, 1996.
Gill et al., “Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity,”J. Biol. Chem., 259:7755-7760, 1984.
Green and Couchman, “Differences in human skin between the epidermal growth factor receptor distribution detected by EGF binding and monoclonal antibody recognition,”J. Invest. Dermatol., 85(3):239-245, 1985.
Green and Couchman, “Distribution of epidermal growth factor receptors in rat tissues during embryonic skin development, hair formation, and the adult hair growth cycle,”J. Invest. Dermatol., 83(2):118-123, 1984.
Green et al., “Distribution and number of epidermal growth factor receptors in skin is related to epithelial cell growth,”Dev. Biol., 100:506-512, 1983.
Hansen et al., “Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development,”Am. J. Pathol., 150(6):1959-1975, 1997.
Harmon et al., “Bisindolylmaleimide protein-kinase-C inhibitors delay the decline in DNA synthesis in mouse hair follicle organ cultures,”Skin Pharmacol., 10:71-78, 1997.
Korc et al., “Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha,”J. Clin. Invest., 90:1352-1360, 1993.
Lokshin et al., “Mechanisms of growth stimulation by suramin in non-small-cell lung cancer cell lines,”Cancer Chemother Pharmacol., 43:341-347, 1999.
Luettcke et al., “The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase,”Genes Dev., 8:399-413, 1994.
Maiorano and Favia, “Expression of phosphotyrosine in squamous cell carcinoma of the oral mucosa. Preliminary study,”Boll. Soc. Ital. Biol. Sper., 71(5-6):157-162, 1995.
Maiorano et al., “Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa,”J. Pathol., 185:167-174, 1998.
Murillas et al., “Expression of a dominant negative mutant of epidermal growth factor receptor in the epidermis of transgenic mice elicits striking alterations in hair follicle development and skin structure,”EMBO J., 14(21):5216-5223, 1995.
Nameda et al., “Endotoxin-induced L-arginine pathway produces nitric oxide and modulates the Ca2+ activated K+ channel in cultured human dermal papilla cells,”J. Invest Dermatol., 106:342-345, 1996.
Saleh et al., “Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiation,”Cancer Biother. Radiopharm, 14:451-463, 1999.
Smythe et al., “The activity of HMG-CoA reductase and acetyl-CoA carboxylase in human apocrine sweat glands, sebaceous glands, and hair follicles is regulated by phosphorylation and by exogenous cholesterol,”J. Invest. Dermatol., 111:139-148, 1998.
van Oijen et al., “Increased expression of epidermal growth factor receptor in normal epithelium adjacent to head and neck carcinomas independent of tobacco and alcohol abuse,”Oral Dis., 4(1):4-8, 1998.
Wagner et al., “Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo,”Gastroenterology, 114:798-807, 1998.
Wang, et al., “Effects of in vivo treatments of nicotine and benzo[a]pyrene on the epidermal growth factor receptor in hamster buccal pouch,”Toxicology, 107:31-38, 1996.
Wang et al., “Identification of epidermal growth factor receptor in human buccal mucosa,”Arch. Oral Biol., 35(10):823-828, 1990.
Whitcomb et al., “Immunohistochemical mapping of epidermal growth-factor receptors in normal human oral soft tissue,”Arch. Oral Biol., 38(9):823-826, 1993.
Yamada et al., “Evaluation of epidermal growth factor receptor in squamous cell carcinoma of the oral cavity,”Oral. Surg. Oral Med. Oral Pathol., 73:67-70, 1992.
Yamanaka et al., “Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness,”Anticancer Res., 13:565-569, 1993.
Yamanaka et al., “Overexpression of HER2
eu oncogene in human pancreatic carcinoma,”Hum. Pathol., 24:1127-1134, 1993.
Albanell et al., “Pharmacodynamic studies of the specific oral EGFR tyrosine kinase inhibitor (EGFR-TKI) zd1839 (‘Iressa’) in skin from cancer patients partcipating in phase I trials: histopathological and molecular consequences of receptor inhibition,”European Journal of Cancer, 37(Supp. 6): S159, 2001.
Parker et al., “Preferential activation of the epidermal growth factor receptor in human colon carcinoma liver metastases in nude mice,”J. of Histochemistry and Cytochemistry, 46(5):595-602, 1998.
Pollack et al., “Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: dynamics of receptor inhibition in situ and antitumor effects in athymic mice,”J. Pharmacology and Experimental Therapeutics, 291(2):739-748, 1999.
Bucana Corazon D.
Fidler Isaiah J.
Board of Regents the University of Texas System
Fulbright & Jaworski L.L.P.
Ungar Susan
LandOfFree
Methods for detecting the efficacy of anticancer treatments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for detecting the efficacy of anticancer treatments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for detecting the efficacy of anticancer treatments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3911670